3
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Naltrexone for opioid dependence: evaluation of a manualized psychosocial protocol to enhance treatment response

Pages 67-78 | Published online: 12 Jul 2009

  • Julius D, Renault F (eds). Narcotic antagonist: naltrexone progress report. NIDA Res Monogr 1976:9.
  • Ling W, Wesson D. Naltrexone treatment for addicted health-care professional: a collaborative private practice experience. J Clin Psychiatry 1984;45:46-8.
  • Washton A, Pottash A, Gold M. Naltrexone in addicted business executives and physicians. J Clin Psychiatry 1984;45:39-41.
  • Brahen L, Henderson R, Capone T, Kordal N. Naltrexone treatment in a jail work release program. J Clin Psychiatry 1984;45:49-52.
  • Cornish JW, Metzger D, Woody GE, et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 1997;14:529-34.
  • Greenstein R, Arndt I, McLellan AT, O'Brien C, Evans B. Naltrexone: clinical perspectives. J Clin Psychiatry 1984;45:25-8.
  • Meyer RE, Mirin SM, Altman J, McNamee HB. A behavioral paradigm for the evaluation of narcotic antagonists. Arch Gen Psychiatry 1976;33:371.
  • Tennant FS, Rawson RA, Cohen AM, Mann AJ. Clinical experience with naltrexone in 160 suburban opioid addicts. J Clin Psychiatry 1984;45:42-5.
  • Callahan EJ, Rawson RA, Glazer M, McLeave B, Arias R, Liberman RB. Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy. NIDA Res Monogr 1976;9:134-40.
  • Rawson RA, Glazer M, Liberman RB. Behavior therapy and naltrexone for narcotic addiction. In: Krasnegor, N, ed. Behavioral approaches to analysis and treatment of substance abuse. NIDA Res Monogr. 1979;15:76-83.
  • Resnick RB, Rawson RA, Washton AM, Stone-Washton N. Psychotherapy and naltrexone in opioid dependence. Presentation to the American Psychiatric Association Meeting, August, 1985: Washington, DC.
  • Anton RF, Hogan I, Jalai B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opioid dependence. Drug Alcohol Depend 1981;8:157-68.
  • Grabowski J. Effects of contingent payment on compliance with a naltrexone regime. Am J Drug Alcohol Abuse 1979;6:355-65.
  • McCann MJ, Miotto K, Rawson RA, Huber A, Shoptaw S, Ling W. Outpatient non-opioid detoxification for opioid withdrawal: who is likely to benefit? Am J Addict 1997;6:1-6.
  • Miotto K, McCann MJ, Rawson RA, Frosch D, Ling W. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug Alcohol Depend 1997;45:131-4.
  • McLellan AT, Luborsky L, Woody GE, O'Brien CP. Guide to the Addiction Severity Index. Washington, DC: US Government Printing Office, 1985.
  • Derogatis LR, Lazarus L. SCL-90, Brief inventory and matching rating scales. In: Maruish ME, ed. The use of psychological testing for treatment planning and outcome assessment. Hillsdale, NJ: Lawrence Erlbaum Associates Inc., 1994:217-48.
  • McNair DM, Loor M, Droppleman LE Profile of mood states. San Diego: Educational and Industrial Testing Services, 1972.
  • Hulse GK, Basso, MR. The association between naltrexone compliance and daily supervision. Drug Alcohol Rev 2000;19:41-8.
  • Azrin NH, Sisson RW, Meyers R, Godley M. Alcoholism treatment by disulfiram and community reinforcement therapy. J Behav Ther Exp Psychiatr 1982;13:105-12.
  • Rawson RA, Obert JL, McCann MJ, Ling W. The Matrix model for the treatment of opioid addiction with naltrexone. Beverly Hills, CA: Matrix, 1992.
  • Ling W, Shoptaw S, Wesson D, Rawson RA, Compton M, Klett CJ. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res Monogr 1998;175:208-20.
  • Miotto K, McCann MJ, Basch J, Rawson, R, Ling, W. Naltrexone and dysphoria: fact or fiction. Am J Addict, in press.
  • Lerner AG, Sigal M, Gelkopf M. Naltrexone abuse and risk of suicide. J Nerv Ment Dis 1993;181:706-7.
  • Office of National Drug Control Policy Pulse check: national trends in drug abuse. Washington, DC: Office of National Drug Control Policy, 1997.
  • Seoane A, Carrasco G, Cabre L, et al. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry 1997;17:340-5.
  • Greenstein RA, O'Brien CP. Alternative pharmacotherapies for opioid addiction. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG eds. Substance abuse: a comprehenive textbook. Baltimore: Williams and Wilkins, 1995:562-573.
  • Farren CK, O'Malley S, Rounsaville B. Naltrexone and opioid abuse. In: Stine S, Kosten TR, eds. New treatments for opioid dependence. New York: Guilford, 1997:104-23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.